Brain connectivity changes occurring following cognitive behavioural therapy for psychosis predict long-term recovery by Mason, L et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1038/tp.2016.263
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Mason, L., Peters, E., Williams, S. C., & Kumari, V. (2017). Brain connectivity changes occurring following
cognitive behavioural therapy for psychosis predict long-term recovery. Translational psychiatry, 7(1), e1001.
10.1038/tp.2016.263
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 18. Feb. 2017
OPEN
ORIGINAL ARTICLE
Brain connectivity changes occurring following cognitive
behavioural therapy for psychosis predict long-term recovery
L Mason1, E Peters1,2, SC Williams3 and V Kumari1,2
Little is known about the psychobiological mechanisms of cognitive behavioural therapy for psychosis (CBTp) and which speciﬁc
processes are key in predicting favourable long-term outcomes. Following theoretical models of psychosis, this proof-of-concept
study investigated whether the long-term recovery path of CBTp completers can be predicted by the neural changes in threat-
based social affective processing that occur during CBTp. We followed up 22 participants who had undergone a social affective
processing task during functional magnetic resonance imaging along with self-report and clinician-administered symptom
measures, before and after receiving CBTp. Monthly ratings of psychotic and affective symptoms were obtained retrospectively
across 8 years since receiving CBTp, plus self-reported recovery at ﬁnal follow-up. We investigated whether these long-term
outcomes were predicted by CBTp-led changes in functional connections with dorsal prefrontal cortical and amygdala during the
processing of threatening and prosocial facial affect. Although long-term psychotic symptoms were predicted by changes in
prefrontal connections during prosocial facial affective processing, long-term affective symptoms were predicted by threat-related
amygdalo-inferior parietal lobule connectivity. Greater increases in dorsolateral prefrontal cortex connectivity with amygdala
following CBTp also predicted higher subjective ratings of recovery at long-term follow-up. These ﬁndings show that reorganisation
occurring at the neural level following psychological therapy can predict the subsequent recovery path of people with psychosis
across 8 years. This novel methodology shows promise for further studies with larger sample size, which are needed to better
examine the sensitivity of psychobiological processes, in comparison to existing clinical measures, in predicting long-term
outcomes.
Translational Psychiatry (2017) 7, e1001; doi:10.1038/tp.2016.263; published online 17 January 2017
INTRODUCTION
Psychotic experiences can be highly distressing and people
experiencing psychosis often also show high levels of emotional
disturbances.1 Although effective pharmacological and psycholo-
gical interventions exist, high rates of relapse remain,2 and
residual symptoms and distress typically persevere between
episodes, for example.3 Identifying the treatment factors that
predict favourable recovery pathways is an important step
towards improving future interventions.
An important step forward in evidence-based practice, across
psychiatric disorders, has been the use of objective clinical
measures for the purpose of outcome monitoring in individuals,
therapists and services.4 Although increasingly important in
service-level clinical decision-making, including allocation of
resources and funding,5 these measures remain poor in predicting
long-term outcomes. In psychosis, for example, a recent meta-
analysis showed that both clinical and demographic variables are
poor predictors of relapse, with non-signiﬁcant effects observed
for psychosis symptoms (either positive or negative), affective
symptoms or clinician-rated insight.6 Measuring change at the
level of the psychological processes that generate and maintain
these symptoms may be helpful in improving the treatment
evaluation as well as for predicting long-term outcomes.
Theoretical models of psychosis postulate that aberrant threat
processing is key in generating and maintaining positive
symptoms.7,8 The psychological processes involved in threat are
problematic to quantify by self-report measures due to subjective
bias (both for patient and clinician). Functional neuroimaging has
yielded robust and objective markers of threat processing in
psychosis.9,10 Recently, there has been increasing interest in
utilising these psychobiological markers to investigate the neural
mechanisms of psychological therapies (for reviews see Barsaglini
et al.11 and Mason et al.12). In psychosis, two reports have arisen
from an investigation of cognitive behavioural therapy for
psychosis (CBTp) compared with treatment-as-usual.13,14 In the
ﬁrst study, we reported reduction in brain response to social threat
from pre- to post- CBTp functional MRI (fMRI) measurements.13
Recently, we further showed that these activation changes were
accompanied by reorganisation of numerous connections with
prefrontal cortical and with several limbic brain regions.14 In line
with our hypotheses, we found that connectivity between
dorsolateral prefrontal cortex (DLPFC) and amygdala increased
following CBTp. Under cognitive neuroscience models of emotion
regulation, this could indicate an increased ability to contextualise
potential social threat and thereby cognitively regulate negative
affect,15,16 which ﬁts with psychological treatment models of
CBTp.10,11 An important ﬁnding was that the vast majority of
connectivity changes did not correlate with symptom change,
suggesting that they captured other CBTp-speciﬁc changes
involved in socio-affective processing, over and above the
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symptom improvement captured by routine clinical measures. The
two connectivity changes to correlate with improvement in
psychotic symptoms were increases in DLPFC connectivity with
inferior parietal lobule (IPL, when processing social threat) and
with postcentral gyrus (when processing prosocial facial affect).
The IPL has previously been associated with theory of mind and
cognitive insight in schizophrenia,14,17,18 and cognitive insight,
which includes self-reﬂectiveness, has been shown to increase
following CBTp,19 providing a plausible route by which changes in
functional threat-related connectivity may mediate improvement
in positive psychotic symptoms. An unexpected ﬁnding was that
symptom improvement was also associated with DLPFC-
postcentral gyrus connectivity, which may be understood in
terms of its putative involvement in the mirror neuron system,
speciﬁcally in somatic aspects of empathy during the processing
of facial affect.14,20 In support of this, abnormalities in this region
have been associated with deﬁcits in emotion recognition21,22 and
to correlate with psychotic symptoms.23 In line with this view, we
found the symptom association was present for the processing of
prosocial (rather than threatening) facial affect, which may be
related to the assertion that paranoia may be secondary to the
misperception of benign affect as threatening, for example.24
In the present study, we sought to examine whether these
CBTp-led changes in socio-affective processes are determinants of
long-term clinical outcomes. To this end, we employed novel
investigation methods to retrospectively follow-up a previously
reported cohort13,14 over ~ 8 years since they received CBTp.
Given the high variability in psychotic symptoms over time, both
in terms of relapse as well as between-episode ﬂuctuation of
residual symptoms,3 we obtained monthly measurements instead
of relying on a single follow-up ‘snapshot’ (see ‘Materials and
Methods’ section).
We predicted that the degree to which threat-related DLPFC-
amygdala connectivity increased following CBTp would predict
greater long-term remission in both positive psychotic symptoms
and affective symptoms, given the importance of this connection
in contextualising potential social threat and in regulating
affect.15,16 Being key to affective well-being, we further predicted
that this connectivity would determine subjective ratings of
recovery at long-term follow-up. Finally, we predicted that the
CBTp-led increases in amygdalo-IPL and DLPFC-postcentral gyrus
Table 1. Demographics, task performance and clinical characteristics of participants
Entire CBTp group (n= 22, 18 male) Long-term follow-up (n= 15, 11 male) Group difference
Mean (s.d.) Mean (s.d.)
Age (years) 35.7 (7.82) 37.9 (7.56) t(20)= 2.14, P= 0.045
Education (years) 13.9 (3.26) 14.1 (3.08) t(20)= 0.324, P= 0.75
Predicted IQa 109.4 (9.68) 110.4 (8.14) t(20)= 0.68, P= 0.5
Age at illness onset 24.8 (8.38) 26.4 (8.99) t(20)= 1.48, P= 0.15
Duration of illness (years) 10.9 (7.70) 11.4 (8.76) t(20)= 0.429, P= 0.67
Medication Atypical antipsychotic (n= 20);
combined atypical and typical (n= 2)
Atypical antipsychotic (n= 14);
combined atypical and typical (n= 1)
Chlorpromazine equivalent (mg) 543 (479.3) 512.9 (450) t(20)= 0.295, P= 0.77
Pre-therapy Post-therapy Pre-therapy Post-therapy
Gender discrimination accuracy (%)
Neutral 92.6 (10.8) 91.8 (13.1) 91 (14.1) 90.8 (10.5) F(1, 20)= 0.122, P= 0.73
Fear 90.5 (14.4) 91.4 (16.5) 92.1 (11.2) 91.7 (15.7) F(1, 20)= 0.267, P= 0.61
Anger 88.6 (15.2) 88.9 (14.2) 94.8 (9.6) 94.2 (7.6) F(1, 20)= 0.045, P= 0.84
Happy 94.7 (8.48) 93.3 (9.94) 94.2 (10.4) 94 (8.6) F(1, 20)= 0.331, P= 0.57
Detection (%)
No face 93.4 (12.4) 91.5 (16.4) 92.4 (13.2) 92.7 (9.5) F(1, 20)= 0, P= 0.98
PANSSb
Positive symptoms 18.1 (4.84) 14.9 (4.10)c 17.7 (4.4) 14.3 (4)d F(1, 20)= 0.089, P= 0.77
Negative symptoms 17.7 (4.23) 15.6 (4.29)c 17.3 (4.4) 15.6 (4.4)d F(1, 20)= 0.7, P= 0.41
General psychopathology 33.5 (7.24) 28.6 (7.40)c 32.6 (5.6) 27.2 (6.8)d F(1, 20)= 0.22, P= 0.64
Total symptoms 69.3 (13.3) 59.0 (14.7)c 67.5 (11.1) 57.1 (14)d F(1, 20)= 0.02, P= 0.9
Beck Depression Inventory 16.2 (8.3)e 11.5 (9.9)c,e 16.7 (9.7) 9.9 (10.2)d F(1, 18)= 2.34, P= .11
Rosenberg self-esteem 24.8 (6.3) 22.7 (5.3) 24 (6.3) 22.6 (5.3)d F(1, 20)= 0.74, P= 0.4
Beck cognitive insight scale
Self-certainty 5.5 (3.5) 4.1 (4) 5.2 (3.6) 4.7 (4.6) F(1, 20)= 1.23, P= 0.27
Self-reﬂectiveness 17.3 (5.8) 14.9 (5.7) 17.3 (5.9) 15.3 (5.7) F(1, 20)= 0.01, P= 0.93
Composite 11.8 (6.9) 10.9 (7.3) 12.1 (7) 10.8 (7.5) F(1, 20)= 0.75, P= 0.4
Birchwood insight scale 10.1 (2.1) 9.9 (2) 10.2 (1.6) 10.1 (1.4) F(1, 20)= 0.18, P= 0.68
Abbreviations: CBTp, cognitive behavioural therapy for psychosis; PANSS, Positive and Negative Syndrome Schedule. aNational adult reading test.25 bPositive
and negative syndrome scale.26 cSigniﬁcant symptom reduction following CBTp previously reported in the full sample.14 dWe did not test for symptom
reductions within the subgroup that was followed up as no group differences in symptom change were found between this subgroup and the full sample
(ﬁnal column). eMissing data for one participant. There were no differences in pre- to post-therapy change between the full group previously reported and
those available for the present follow-up study in terms of performance, symptom change or other clinical measures.
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connectivity that had previously been associated with improve-
ment in psychotic symptoms following CBTp,14 would predict
greater levels of remission in this symptom domain.
MATERIALS AND METHODS
Participants and design
Participants were 22 outpatients with a conﬁrmed diagnosis of paranoid
schizophrenia (ﬁnal N=15; see Table 1) who had taken part in our earlier
studies.13,14 These participants had completed an fMRI implicit facial
affective processing task and a battery of clinical measures on two
occasions, pre (T1) and post (T2) receiving 6 months of CBTp. Sixteen
outpatients receiving treatment-as-usual were also scanned at these time
points (data not analysed as part of the present study).
Procedure
We retrospectively followed up these participants as their ﬁnal fMRI scan
(at T2), an average of 8 years (range 7–9 years) before the current study
(T3). We obtained objective clinical outcomes for this entire period through
case note review (T2 to T3; see Longitudinal Clinician Ratings) as well as
current subjective ratings of recovery and well-being (at T3; see Outcome
Measures).
Consent was obtained by seeking current contact details from consultant
clinicians in the services providing care for the previously recruited
participants. Participants were then contacted by phone and those
expressing an interest received information about the study, a consent
form for accessing their electronic clinic records, self-report questionnaires
assessing well-being and recovery and a prepaid envelope. The ﬁnal sample
of participants who consented and returned the questionnaires were
reimbursed £10 for their time. Ethical approval was granted by the National
Health Service research ethics committee (reference: 14/LO/0325).
Functional neuroimaging procedure. As described in earlier reports,14
participants were presented with monochrome faces depicting fear, anger,
happiness or neutral expressions,27 and had to indicate the sex of the face
with a button press response. These were repeated in four blocks per
condition, with counterbalancing across 16 blocks (see Mason et al.14 and
Supplementary Material for further details of the scanning protocol).
Changes in functional connectivity from T1 to T2 were quantiﬁed during
social threat (angry faces) and prosocial social affect (happy faces) using
the psychophysiological interaction approach.28 Seeds were left amygdala
and right DLPFC; whereas bilateral activation was found, we selected the
regions of maximum task activation that were reported previously.16 Seeds
were deﬁned functionally from the group-level maxima, with spheres
around these maxima (3 and 4 mm radius for amygdala and DLPFC,
respectively). These were additionally constrained within anatomical masks
for these regions as deﬁned by the PickAtlas toolbox.29 Signiﬁcant
connectivity changes following CBTp were tested by examining the
interaction of group (CBTp vs treatment-as-usual) by time (T1 vs T2). There
were exclusively increases in connectivity in the CBTp group across
functional connections with amygdala and DLPFC.
For the present study, we focused our analyses on the change in DLPFC-
amygdala connectivity that occurred during social threat processing,
because of the strong theoretical link with cognitive regulation of
affect15,16 and in turn the relevance to cognitive behavioural models of
positive symptoms of psychosis.7,8 We also included the two connectivity
changes that previously correlated with improvement in positive psychotic
symptoms: amygdala-IPL and DLPFC-postcentral gyrus, which had
occurred for the processing of threat and prosocial facial affect,
respectively.14
Cross-sectional clinical measures. The following clinician-administered and
self-report measures had previously been administered pre- and post-
CBTp (T1 and T2). The Positive and Negative Syndrome Schedule
(PANSS);26 is a clinician-administered rating of positive, negative and
general psychopathology symptoms. Affective symptoms were measured
from the Beck Depression Inventory, second edition.30
We acquired additional measures at long-term follow-up (T3). We
assessed subjective recovery using the Questionnaire about the Process of
Recovery (QPR,31), a service-user led instrument that follows theoretical
models of recovery and provides a measure of constructs such as hope,
empowerment, conﬁdence, connectedness to others. This was our primary
measure as it has one of the best psychometric properties of recovery
measures32 and can be expected to be relatively robust to ﬂuctuations in
clinical state, making it well suited to use a cross-sectional measurement of
long-term outcome. Additional measures for well-being, satisfaction and
functioning were acquired (Supplementary Materials) but were not
included in analyses because of missing observations, a high correlation
with self-reported recovery and to reduce the number of analyses
reported. These data are available on request from the ﬁrst author.
Longitudinal clinician ratings of symptoms: We retrospectively
determined symptoms and functioning from electronic case note data
held by local National Health Service trusts in South London. This covered
the entire period between participants’ ﬁnal fMRI measurements (T2; circa
2007) and January 2015 (T3). Two raters followed validated operationalised
criteria33 to infer presence of positive psychotic symptoms for each month
independently, based on clinical note entries made by mental health
professionals. Participants were rated as being in ‘full remission’ (no
symptoms present), ‘partial remission’ (symptoms of low intensity or
frequency with clinicians noting at least partial insight), or ‘no remission’
(moderate symptoms; see Bebbington et al.33 for fully detailed criteria).
Ratings of affective symptoms were based on both the intensity and
frequency of affective disturbance as follows. Affective symptoms were
rated as ‘low’ when there was no indication of distress or only brief periods
(o3 days, maximum of two separate instances for that month) of mild-to-
moderate severity (without expression of suicidality and that did not
require intervention by mental health professionals). ‘Moderate’ affective
symptoms was rated where there was any period of distress lasting more
than 3 days, where there was expression of suicidality not requiring severe
management, or where there were three or more instances of ‘low’
affective symptoms present for that month. ‘Severe’ was rated for any
month in which there was severe distress and suicidality requiring severe
management, including hospitalisation or home treatment care. This
method was shown to have high reliability and clinical validity,33 with
strong associations between the ratings of symptoms made by case note
ratings and PANSS in the same participants. We conﬁrmed that reliability
was also high for ratings made in the present study, with inter-rater
agreement ranging from ‘moderate’ to ‘almost perfect’ (Supplementary
Materials).
In addition to these symptom ratings, we also rated level of care needed
(categories: care of general practitioner only; outpatient appointments in
secondary care; daily home treatment; hospital treatment) and occupa-
tional functioning (paid employment; voluntary work or training course;
unemployed), as a mean of validating the clinical ratings (Supplementary
Table 1). There were signiﬁcant positive associations between the non-
remission measure and amount of severe care (hospitalisation and home
treatment; see Supplementary Table 2).
Data analysis
Prediction of long-term outcomes from functional connectivity changes.
Multivariate analysis of variance (MANOVA, Wilk’s Lambda) was used to
relate the longitudinal, month-by-month clinician ratings of psychotic and
affective symptoms (T2 to T3) as well as subjective recovery (T3), to the
functional connectivity changes (T1 to T2) as follows. All tests were
performed one-tailed.
Percentage of months spent in each of the three symptom states was
computed for positive psychotic symptoms (full, partial or non-remission)
and for affective symptoms (low, moderate or severe). To simplify the
analyses and to reduce model over-ﬁtting, we computed a single residualised
variable for each symptom domain (see Supplementary Materials for details).
The effect of psychotic and affective symptom domains was tested
separately, by entering the respective symptom variable as a regressor
within MANOVA, along with our hypothesised changes in connectivity as
dependent variables. Bonferroni correction was applied for multiple tests (p/
2) across the two symptom domains and signiﬁcant effects were followed up
using correlation tests (Spearman; rρ) to clarify the direction of associations.
We also performed an exploratory analysis to address the hypothesis
that the therapeutic effects of CBTp would be better captured by changes
to core threat processes than by short-term symptom reduction.14,34
Because of the exploratory nature, this analysis is reported as
Supplementary Material.
Finally, we separately tested the relationship between the functional
connectivity changes and long-term subjective recovery, the total score of
which was entered as a regressor into MANOVA with the functional
connectivity changes as dependent variables.
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RESULTS
Long-term clinical outcomes
At long-term follow-up, consent was obtained to access case note
data for 15 of the 22 CBTp group (age = 37.9, s.d. = 7.56; 11 male).
This subsample did not differ in terms of response to CBT, either in
terms of improvement in psychotic symptoms or in depressive
symptoms, and additionally did not differ in task performance
(Table 1). These participants evidenced high rates of remission,
with an average of 93.5% of months spent in either full or partial
remission and evidenced by low rates of affective symptoms
overall, with an average of 88.2% of months with low affective
symptoms (Supplementary Table 1). As expected, symptom
remission was highly associated with level of care
(Supplementary Table 2), with months in non-remission positively
correlating with months receiving hospital care and months
receiving intensive home treatment. Months in non-remission
were also positively correlated with months of severe affective
symptoms (Supplementary Table 2).
Prediction of long-term outcomes from functional connectivity
changes
Longitudinal positive psychotic symptoms. Neither of the threat-
related connections were signiﬁcant in the model for long-term
positive psychotic symptoms (P⩾ 0.42). There was a signiﬁcant
effect for the prosocial facial affect connection (change in DLPFC-
postcentral gyrus connectivity; F(1, 13) = 7.83, corrected-P= 0.03),
which was driven by a positive association (rρ(15) = 0.495, P= 0.06;
Figure 1). There was no multivariate level effect (corrected-
P= 0.12).
Longitudinal affective symptoms. There was a signiﬁcant effect
speciﬁcally for the change in threat-related connectivity between
amygdala and IPL (F(1, 13) = 7.72, corrected-P= 0.032), but not
DLPFC-amygdala connectivity (P40.99). This signiﬁcant effect was
conﬁrmed to be a positive association (rρ(15) = 0.49, P= 0.06)
(Figure 1). There was no effect for the change in prosocial facial
affect connectivity (corrected-P= 0.24). The multivariate level
effect approached signiﬁcance (F(3, 11) = 4.35, corrected-P= 0.06).
Subjective long-term recovery
There was a signiﬁcant effect speciﬁcally for the change in threat-
related connectivity between amygdala and DLPFC (F(1, 13) = 6.54,
corrected-P= 0.04), which was positively associated with long-
term recovery (rρ(15) = 0.51, P= 0.05) (Figure 2). There was no
difference in the strength of association between the connectivity
change and the ‘intrapersonal’ and ‘interpersonal’ subscales of
recovery (P= 0.82). There was no effect for the other connectivity
changes (corrected-P⩾ 0.32) or at the multivariate level (cor-
rected-P= 0.11).
Figure 1. Following cognitive behavioural therapy for psychosis, the change in speciﬁc social-affect functional connections differentially
predicts level of positive psychotic symptoms (top) and affective symptoms (bottom) across eight years. Top: the increase in connectivity
between dorsolateral prefrontal cortex (DLPFC) and postcentral gyrus when processing prosocial facial affect predicted reduced levels of
positive psychotic symptoms (rρ(15)= 0.495, P= 0.06). Bottom: conversely, the increase in amygdala connectivity with the inferior parietal
lobule (IPL) when processing social threat predicted reduced levels of affective symptoms (rρ(15)= 0.49, P= 0.06). Dotted lines between brain
regions represent connectivity.
Neural changes from psychotherapy predict long-term recovery
L Mason et al
4
Translational Psychiatry (2017), 1 – 7
DISCUSSION
This study utilised an innovative methodology that combined
functional neuroimaging with monthly clinician ratings of
symptoms over a substantial eight-year period. We showed that
the reorganisation that occurs at the neural level following
psychological therapy can predict the subsequent recovery path
of people with psychosis across this entire period (Figure 1).
In this study, the sole predictor of long-term positive psychotic
symptoms was the degree to which prefrontal cortical connectiv-
ity with postcentral gyrus had been promoted following CBTp,
speciﬁcally for the processing of prosocial (rather than threaten-
ing) facial affect (Figure 1, upper panel). When processing facial
affect, this connection may integrate somatic aspects of affective
empathy with higher-order appraisals.14,20 It has been proposed
that paranoia is causally linked to a tendency to misperceive
benign affect as threatening, for example.24 Our ﬁnding that
remission of positive psychotic symptoms (including paranoia) is
determined by improvement in neural processes supporting affect
recognition and empathy represents a novel psychobiological
mechanism for CBTp.
Long-term affective symptoms were, on the other hand,
predicted by a separate connection involved in the processing
of potential social threat, speciﬁcally the degree to which
connections had strengthened between amygdala and IPL
(Figure 1, lower panel). Functional IPL networks have been linked
to the allocation of attention35 as well as to theory of mind,36 and
so one interpretation of the present ﬁndings would be that the
ability to adequately allocate attention to and engage with the
affect of others is important for long-term emotional well-being.
Our hypothesis that affective symptoms would be predicted by
top-down cognitive regulation of affective regions, putatively
instantiated in DLPFC-amygdala connectivity, was not supported
however. This connection did, however, predict participants’
subjective sense of recovery at long-term follow-up (Figure 2). It
seems plausible to conclude that being better able to cognitively
regulate negative emotion, especially in response to potential
threat, is an important CBTp outcome that determines personally
perceived recovery in the long run. This is concordant with service
user-focused research, which has highlighted that the ability to
better manage negative emotionality is an important feature of
recovery for people with psychosis.31 Overall, these ﬁndings
highlight that neural changes following CBTp confer a long-lasting
beneﬁt.
The possibility that separate psychobiological mechanisms
mediate long-term affective and psychotic symptom domains
builds on the view that CBTp can effectively alleviate distress and
affective disturbances without necessarily altering psychotic
symptoms themselves, for example37 and raises the possibility
that changes in threat-related processing, speciﬁcally amygdalo-
IPL connectivity, may be sufﬁcient for long-term emotional well-
being. This interpretation should be treated as preliminary until
replicated because participants here had evidenced improve-
ments in psychotic symptoms following CBTp (and not just
affective symptoms; Table 1) and our supplementary analysis
found evidence of common connections predicting both symp-
tom domains (Supplementary Materials).
One of our aims was to establish to incremental value of using
change in psychobiological processes as predictors of long-term
outcomes over existing clinical measures. Although the ﬁnal
sample size was relatively small, and so replication is needed, we
found preliminary evidence that these changes in socio-affective
processing may be superior to short-term improvements in
symptoms in predicting people’s long-term symptoms and
recovery proﬁles (Supplementary Materials). Measuring change
at the level of the psychological processes that are theorised to
generate and maintain symptoms may be a more informative
means of evaluating treatment.
We believe this is the ﬁrst investigation of its kind in psychosis
and also extends two longitudinal studies in anxiety disorders,
which used a single follow-up time point, 6–12 months after
psychological therapy.38,39 Consistent with the CBTp-led promo-
tion of a putatively amygdala-modulating circuit reported here,
Furmark et al.39 found that CBT-led reductions in amygdalo-limbic
activation predicted better clinical outcomes in social anxiety
disorder patients. The same group have also shown limbic
connectivity to be important in predicting treatment response,
using a similar socio-affective processing task to ours.40 This
overlap in psychobiological processes is consistent with the view
that anxiety is inherent in the formation and maintenance of
paranoia.41
There are several limitations to note of the present study. First,
as is typical for follow-up studies, especially of this timespan, there
was a high attrition rate. Although the ﬁnal sample size remained
adequate according to recommendations, for example,42 further
work with greater statistical power will be needed to replicate and
extend the present ﬁndings, in particular to explore how the
connectivity changes differentially associate with symptom
domains. Second, although the facial affective processing task is
widely utilised in clinical research to elicit threat processing, future
work with more nuanced designs will be necessary to further
elucidate the functional signiﬁcance of these brain connections
and how they can inform development of CBTp treatment models.
Given the economic and practical barriers that limit the use of
neuroimaging in routine clinical practice, it will also be important
to identify pragmatic behavioural analogues for these brain
connectivity markers of social affective processing. Third, although
Figure 2. Functional connectivity changes following cognitive
behavioural therapy for psychosis predict subjective recovery at 8-
year follow-up. A greater increase in connectivity between amygdala
and dorsolateral prefrontal cortex (DLPFC), when processing social
threatening facial affect, was associated with higher levels of
subjective recovery (rρ(15)= 0.51, P= 0.05).
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the inclusion of a clinical control group allowed greater
conﬁdence in attributing the changes in CBTp receivers to the
intervention, we cannot rule out the possibility that the changes
reﬂect symptom improvement that are non-speciﬁc to CBTp,
because symptomatic improvement differed between the groups.
However, this issue is mitigated by the ﬁnding that only two of the
18 connectivity changes previously correlated with pre- and post-
CBTp symptom improvement.14 Studies contrasting CBTp and
pharmacotherapy are ultimately warranted to examine the
speciﬁcity of these psychobiological processes. A related point is
that the medication that CBTp completers received is likely to also
have formed an important part of their overall recovery. Finally,
because allocation to CBTp (vs treatment-as-usual) was not
randomised, we cannot rule out the possibility of a selection
bias. There were no explicit biases in recruitment and the CBTp
group did not show any differences in any of the clinical,
demographic or neural measures included in the study.16
However, we previously reported that verbal intelligence (but
not in other cognitive functions) was elevated in the CBTp
completers compared with treatment-as-usual participants.43 It is
possible that this conferred an advantage in terms of response
to CBTp.
Our previous investigation14 provided evidence that CBTp leads
to substantial reorganisation of functional connectivity supporting
social affective processing, relatively little of which is captured by
measures of symptom change. The present ﬁndings extend this
work by providing initial evidence that it is the degree to which
this reorganisation takes place that determines sustained gains in
the long-term recovery of people with psychosis. This justiﬁes
further work utilising this novel methodology on a larger scale.
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